Human Basophil Phenotypes and Therapeutic Outcomes
人类嗜碱性粒细胞表型和治疗结果
基本信息
- 批准号:8707080
- 负责人:
- 金额:$ 44.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-15 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAllergensAllergicAllergic DiseaseAllergic ReactionAsthmaBasophilsBindingBiologicalBiologyCellsCharacteristicsChronicClinicalComplexDevelopmentEnvironmentFood HypersensitivityGeneral PopulationGenesGoalsHumanIgEImmediate hypersensitivityInterleukin-3LeadLinkMediatingMessenger RNAMolecularNatureOutcomeParticipantPathogenesisPatientsPharmaceutical PreparationsPhenotypePilot ProjectsProcessRNAReactionSeriesTherapeuticTranscriptUrticariaanalytical toolatopybaseclinical phenotypecomparativecytokinein vivoinsightmast cellnovel strategiesomalizumabresponsetool
项目摘要
DESCRIPTION (provided by applicant): Allergic diseases are characterized, in part, by the activities of mast cells and basophils. These cells bind circulating IgE and subsequently become responsive to allergen exposure. In addition to this IgE-dependent part of the reaction, the phenotype of the cell also determines the nature of its responses to both allergens and other biological molecules in the environment of the cell. A variety of studies have implicated the basophil in the immediate hypersensitivity reactions that are part of the allergic condition. In addition, studies during the last 3-4 decades have repeatedly made note of several basophil phenotypes that track with different allergic disease states. Despite the importance of the basophil in immediate hypersensitivity reactions, there have been only cursory efforts to understand the basis for the various basophil phenotypes. One reason for the lack of progress in understanding these phenotypes is that only recently are some of the molecular mechanisms that may modulate the basophil phenotype described well enough to develop hypotheses regarding the phenotypes' origins. Another reason is that the basophil is difficult to study and the tools to properly characterize its phenotype are not available. This application will provide a
new set of analytical tools to explore basophil phenotypes with the intent of applying these tools to the question of basophil phenotypes. RNA signatures are a well- explored approach to characterizing complex phenotypes but they have not been applied to the question of basophil phenotypes due to the difficulties studying this cell. Two approaches are proposed, one based on developing well-defined signatures associated with specific modulators of basophil function and phenotype and the second based on the more general comparisons that can be made between natural phenotypes using a broad-based microarray profile. After developing the focused signatures that are associated with specific basophil modulators, the third specific aim of the proposal will examine three well described basophil phenotypes, the phenotype associated with omalizumab treatment and linked to marked increases in cellular sensitivity, the spontaneous release phenotype associated with food allergies and severe asthma and the suppressed phenotype associated with chronic idiopathic urticaria. It is expected that identification of the basis for the phenotypes will provide new insights into the underlying biolog that drives these allergic conditions.
描述(由申请人提供):过敏性疾病的一部分是由肥大细胞和嗜碱性粒细胞的活性来表征的。这些细胞结合循环IgE,随后对过敏原暴露有反应。除了反应的这一IgE依赖性部分外,细胞的表型还决定了其对过敏原和细胞环境中其他生物分子的反应的性质。各种研究都暗示了嗜碱性粒细胞的直接性高敏反应,这是过敏性疾病的一部分。此外,在过去的3-4年中,研究反复记录了几种跟踪具有不同过敏性疾病状态的嗜碱性粒细胞表型。尽管嗜碱性粒细胞在直接过敏反应中的重要性,但仍有粗略的努力来理解各种嗜碱性粒细胞型的基础。理解这些表型缺乏进展的原因之一是,直到最近才是一些分子机制,这些机制可能调节嗜碱性粒细胞表型的描述足以很好地发展有关表型起源的假设。另一个原因是嗜碱性粒细胞很难研究,并且无法获得正确表征其表型的工具。该应用程序将提供
新的分析工具探索嗜碱性粒细胞表型,目的是将这些工具应用于嗜碱性粒细胞表型问题。 RNA签名是表征复杂表型的一种探索良好的方法,但由于研究该细胞的困难,它们尚未应用于嗜碱性粒细胞表型问题。提出了两种方法,一种基于与嗜碱性粒子功能和表型的特定调节剂相关的定义明确的特征,第二种基于一种基于更一般的比较,可以使用基于广泛的微阵列在自然表型之间进行比较。在开发了与特定嗜碱性粒细胞调节剂相关的聚焦特征之后,该提案的第三个特定目的将检查三种描述良好的嗜碱性粒细胞表型,与omalizumab治疗相关的表型,以及与细胞敏感性的显着增加相关的表型,与食物过敏和抑制式炎症的纯素蛋白质相关的自发释放表型相关。可以预期,表型基础的识别将为驱动这些过敏状况的基本生物学提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald W MacGlashan其他文献
Donald W MacGlashan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald W MacGlashan', 18)}}的其他基金
Regulation of Syk Expression in Human Basophils
人嗜碱性粒细胞中 Syk 表达的调节
- 批准号:
10434940 - 财政年份:2021
- 资助金额:
$ 44.47万 - 项目类别:
Regulation of Syk Expression in Human Basophils
人嗜碱性粒细胞中 Syk 表达的调节
- 批准号:
10633098 - 财政年份:2021
- 资助金额:
$ 44.47万 - 项目类别:
Regulation of Syk Expression in Human Basophils
人嗜碱性粒细胞中 Syk 表达的调节
- 批准号:
10276240 - 财政年份:2021
- 资助金额:
$ 44.47万 - 项目类别:
The Role of CD32 in the Basophil Response to Specific Immunotherapy
CD32 在嗜碱性粒细胞对特异性免疫治疗反应中的作用
- 批准号:
8628227 - 财政年份:2014
- 资助金额:
$ 44.47万 - 项目类别:
The Role of CD32 in the Basophil Response to Specific Immunotherapy
CD32 在嗜碱性粒细胞对特异性免疫治疗反应中的作用
- 批准号:
8810641 - 财政年份:2014
- 资助金额:
$ 44.47万 - 项目类别:
The Role of CD32 in the Basophil Response to Specific Immunotherapy
CD32 在嗜碱性粒细胞对特异性免疫治疗反应中的作用
- 批准号:
8482055 - 财政年份:2012
- 资助金额:
$ 44.47万 - 项目类别:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
IgE 在介导体内过敏反应中的功效
- 批准号:
7914972 - 财政年份:2009
- 资助金额:
$ 44.47万 - 项目类别:
Efficacy of IgE in Mediating Allergic Reactions in Vivo
IgE 在介导体内过敏反应中的功效
- 批准号:
7134190 - 财政年份:2006
- 资助金额:
$ 44.47万 - 项目类别:
FcERI Expression, Cellular Sensitivity, In vivo Response
FcERI 表达、细胞敏感性、体内反应
- 批准号:
7150225 - 财政年份:2006
- 资助金额:
$ 44.47万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 44.47万 - 项目类别:
Identification of gene variants mediating the behavioral and physiological response to THC
鉴定介导 THC 行为和生理反应的基因变异
- 批准号:
10660808 - 财政年份:2023
- 资助金额:
$ 44.47万 - 项目类别:
Determining medications associated with drug-induced pancreatic injury through novel pharmacoepidemiology techniques that assess causation
通过评估因果关系的新型药物流行病学技术确定与药物引起的胰腺损伤相关的药物
- 批准号:
10638247 - 财政年份:2023
- 资助金额:
$ 44.47万 - 项目类别:
TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer
分级姑息治疗:基于人群的护理提供模式,以满足不断变化的患者需求,并为社区心力衰竭或癌症患者提供姑息治疗服务
- 批准号:
10880994 - 财政年份:2023
- 资助金额:
$ 44.47万 - 项目类别: